Eda Zhuleku is an expert with respect to all regulatory issues that may be of interest to pharma, medical device, IVDs and life sciences businesses, including market access strategies, prescription of drugs and medical devices and eligibility for reimbursement.
Eda Zhuleku regularly supports strategic transactions, cross-border product launches and complex regulatory projects, translating evolving legal requirements into commercially practical solutions for innovative healthcare businesses.
Eda Zhuleku regularly supports strategic transactions, cross-border product launches and complex regulatory projects, translating evolving legal requirements into commercially practical solutions for innovative healthcare businesses.
Representative experience
- Mallinckrodt on the regulatory aspects of the international carve-out of its Therakos business comprising medical device and pharmaceutical components and disposal to CVC Capital Partners.
- KühneHolding AG and E3X Partners GmbH in connection with the acquisition of the pharmaceutical contract developer and manufacturer AenovaGroup from the private investment company BC Partners.
- Kyowa Kirin International (KKI) on its joint venture collaboration with global sclence- based, privately owned pharmaceutical company Griinenthal for KKl's established medicines portfolio.
- Vision Healthcare, a consumer healthcare company headquartered in Belgium with an extensive portfolio of self-care brands and over-the-counter products in several European countries, on the acquisition of 100% of the shares of AixSwiss BV, a leading provider of probiotic dietary supplements.
- Bayer in connection with the coordination and strategic advice on the defence and enforcement of intellectual property rights relating to its best-selling drug, Xarelto, throughout Europe.
- Global pharmaceutical companies in patent litigation cases and related pharmaceutical law and regulatory questions
- Carl Zeiss Meditec in connection with a cloud-based digital health platform as well as the implementation of this health platform and related digital solutions.
- Organon on comprehensive regulatory matters relating to medicinal products and medical devices as well as on corresponding distribution channels, import, pharmacovigilance, advertising and product compliance.
- A global pharmaceutical company on issues relating to the regulation of in vitro diagnostics, in particular the placement on the market of Laboratory Developed Tests (LDTs).
- Enovis Corporation on strategic regulatory considerations in connection with investments and expansion activities in the German digital health sector.
Awards and recognitions
- Next Generation Partner, Legal 500, 2025
- Healthcare Rising Star of the Year, Legal 500, 2024
Education
MBA Health Care Management European Business School (EBS)
Lecturer - Drug Regulatory Affairs University of Augsburg/Zentrum für Weiterbildung und Bildungstransfer ( ZWW)
Admissions
- Rechtsanwältin 2018
Speaking engagements
- Panelist at C5´s Market Access Think Tank: Market Access and IP Rights:
- Panelist at Al in Pharma hosted by Al Hub during the Al Week in Frankfurt
- Guest Speaker at Medica-Tradefair: How to navigate the regulatory landscape for companion diagnostics and Al-based medical devices used in clinical trials?
- Lecturer, Drug Regulatory Affairs - Basic Course ai the University of Augsburg
- Lecturer, Health Care Management at the European Business School (EBS)
Languages
- English
- German
- French
Publications
- Zhuleku, E., Günther, S., Preinfalk, F. (2024), “Medical Devices: Sources of Regulation (Germany)”, Practical Law, Thomson Reuters
- Zhuleku E. (2020) “Covid-19 and the Life Science Sector” Practical Law?, London, Thomson Reuters
- Zhuleku E. (2020), “The German Healthcare system and digitalization”, International Journal of Law and Technology
- Zhuleku E, Professor Ehlers A, (2018), „Neues Bundesdatenschutzgesetz und EU? Datenschutzverordnung Anpassungsbedarf bei den Unternehmen“ in pharmind Nr.1, 82, Edition Cantor Verlag
- Zhuleku E, Professor Ehlers A, (2016), „Die FSA?Kodizes und ihre Durchsetzung - wie konsequent ist das“ in: pharmind Nr. 6, 869, Edition Cantor Verlag
- Zhuleku E, (2014), „Die ärztliche Aufklärungspflicht nach dem Patientenrechtegesetz” in: Der Diabetologe, Springer Medizin